P
Patrick C. Y. Woo
Researcher at Li Ka Shing Faculty of Medicine, University of Hong Kong
Publications - 621
Citations - 37320
Patrick C. Y. Woo is an academic researcher from Li Ka Shing Faculty of Medicine, University of Hong Kong. The author has contributed to research in topics: Coronavirus & Gene. The author has an hindex of 85, co-authored 593 publications receiving 31877 citations. Previous affiliations of Patrick C. Y. Woo include The Chinese University of Hong Kong & Kwong Wah Hospital.
Papers
More filters
Journal ArticleDOI
Structural and functional insight into the mechanism of an alkaline exonuclease from Laribacter hongkongensis.
Wen Yang,Wen-yang Chen,Hui Wang,John W. Ho,Jian-Dong Huang,Patrick C. Y. Woo,Susanna K. P. Lau,Kwok-Yung Yuen,Qionglin Zhang,Weihong Zhou,Mark Bartlam,Rory M. Watt,Zihe Rao +12 more
TL;DR: The biophysical, biochemical and structural characterization of recombinant LHK-Exo protein is reported, and a conserved two metal ion catalytic mechanism is proposed for this class of alkaline exonucleases.
Journal ArticleDOI
Eighty years of mycopathologia: a retrospective analysis of progress made in understanding human and animal fungal pathogens
Vishnu Chaturvedi,Jean-Philippe Bouchara,Ferry Hagen,Ana Alastruey-Izquierdo,Hamid Badali,Anamélia Lorenzetti Bocca,José F. Cano-Lira,Cunwei Cao,Sudha Chaturvedi,Sanjay H. Chotirmall,Anne D. van Diepeningen,Jean-Pierre Gangneux,Jesús Guinea,Sybren de Hoog,Macit Ilkit,Rui Kano,Weida Liu,Nilce Maria Martinez-Rossi,Marcia S. C. Melhem,Mario Augusto Ono,Yuping Ran,Stéphane Ranque,Célia Maria de Almeida Soares,Takashi Sugita,Philip A. Thomas,Anna Vecchiarelli,Nancy L. Wengenack,Patrick C. Y. Woo,Jianping Xu,Rosely Maria Zancopé-Oliveira +29 more
TL;DR: An empirical analysis of the publication trends suggests continuing interests in novel diagnostics, fungal pathogenesis, review of clinical diseases especially with relevance to the laboratory scientists, taxonomy and classification of fungal pathogens,fungal infections and carriage in pets and wildlife, and changing ecology and epidemiology offungal diseases around the globe.
Journal ArticleDOI
Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors.
TL;DR: The risk of fungal infection in patients receiving cytokine antagonists and immune checkpoint inhibitors, two big categories of biologic agents that are widely used in the treatment of various autoimmune and malignant conditions, is highlighted.
Journal ArticleDOI
Safety and immune response of a live-attenuated herpes zoster vaccine in patients with systemic lupus erythematosus: a randomised placebo-controlled trial.
TL;DR: In patients with stable SLE not receiving intensive immunosuppression, Zostavax was well-tolerated and provoked an immune response.
Book ChapterDOI
Gene Amplification and Sequencing for Bacterial Identification
TL;DR: Although matrix-assisted laser desorption ionisation-time-of-flight mass spectrometry is an emerging technology for bacterial identification in clinical laboratories, it is not feasible to manually interpret the raw data in case of ambiguous results, so gene sequencing or a polyphasic approach for bacterial Identification is still the standard to resolve difficult cases.